Autonomous Subcutaneous Delivery System

Publication ID: 24-11857218_0010_PTD

Published: November 07, 2025

Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Autonomous Subcutaneous Delivery System,” Published Technical Disclosure No. 24-11857218_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857218_0010_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,218.

Summary of the Inventive Concept

A next-generation subcutaneous delivery tool that leverages advanced materials, artificial intelligence, and modular design to enhance patient safety, reduce healthcare costs, and expand medical applications.

Background and Problem Solved

The original subcutaneous delivery tool patent, while innovative, has limitations in terms of biocompatibility, device removal, and customization. The new inventive concept addresses these limitations by incorporating bio-absorbable materials, nanomaterial coatings, artificial intelligence, and modular design to create a more efficient, safe, and adaptable system.

Detailed Description of the Inventive Concept

The Autonomous Subcutaneous Delivery System consists of a bio-absorbable implantation device that dissolves within a predetermined timeframe, eliminating the need for device removal. The medical device is coated with a nanomaterial that enhances biocompatibility and reduces inflammation. The system is equipped with artificial intelligence that detects anomalies in patient data and alerts healthcare professionals. The modular design allows for interchangeable components, enabling customization of the device for specific medical applications. Additionally, the system incorporates a miniature energy harvesting system, eliminating the need for battery replacement.

Novelty and Inventive Step

The new claims introduce several novel and non-obvious features, including the use of bio-absorbable materials, nanomaterial coatings, artificial intelligence, and modular design. These advancements significantly improve the safety, efficiency, and adaptability of the subcutaneous delivery tool, making it a paradigm-shifting innovation in the field.

Alternative Embodiments and Variations

Alternative embodiments of the Autonomous Subcutaneous Delivery System could include variations in the bio-absorbable material composition, nanomaterial coating thickness, artificial intelligence algorithms, and modular component designs. Additionally, the system could be adapted for use in different medical applications, such as diabetes management or cardiovascular disease monitoring.

Potential Commercial Applications and Market

The Autonomous Subcutaneous Delivery System has significant commercial potential in the medical device industry, with potential applications in chronic disease management, patient monitoring, and personalized medicine. The market for this technology is vast, with potential customers including hospitals, clinics, and pharmaceutical companies.

CPC Classifications

Section	Class	Group
A	A61	A61B17/3468
A	A61	A61B5/29
A	A61	A61B17/32093
A	A61	A61B2017/320044
A	A61	A61B2017/320056
A	A61	A61N1/3756
A	A61	A61N1/37205

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical Device Implantation and Monitoring Technologies, specifically subcutaneous monitoring and delivery systems, requiring expertise in biomedical engineering, medical device design, materials science, and miniature electronic systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, 5-7 years experience in medical device development, familiar with implantable technologies, materials engineering, and emerging medical monitoring techniques

Obviousness Rationale

A person of ordinary skill would recognize that the PTD's proposed variations represent predictable extensions of the source patent's subcutaneous delivery tool framework. The core implantation mechanism remains fundamentally consistent, with incremental improvements in materials, monitoring capabilities, and device functionality. These modifications represent logical technological progressions that would be apparent to a skilled practitioner seeking to enhance subcutaneous medical device performance and patient outcomes.

Obvious Combinations & Variations

Source Patent Element

Implantation device with defined tool body and channel for medical device placement

PTD Variation

Bio-absorbable implantation device that dissolves after predetermined timeframe

Obviousness Reasoning

Material selection for medical implants is a known design choice, with biocompatible and bio-absorbable materials being standard techniques in medical device engineering for reducing long-term patient complications

Source Patent Element

Subcutaneous monitoring device with structural configuration

PTD Variation

Nanomaterial coating to enhance biocompatibility and reduce inflammation

Obviousness Reasoning

Surface modification techniques are well-established in medical device design, with nanomaterial coatings representing a predictable approach to improving device interaction with biological tissues

Source Patent Element

Medical device for subcutaneous placement and monitoring

PTD Variation

Artificial intelligence system for detecting patient data anomalies

Obviousness Reasoning

Integration of intelligent monitoring systems is a foreseeable technological progression, with machine learning algorithms increasingly applied to medical device data interpretation

Source Patent Element

Implantation tool with defined structural components

PTD Variation

Modular design allowing interchangeable components for customization

Obviousness Reasoning

Modular design is a standard engineering approach for increasing device adaptability, representing a routine design optimization strategy in medical technology

Source Patent Element

Subcutaneous monitoring device requiring power source

PTD Variation

Miniature energy harvesting system eliminating battery replacement

Obviousness Reasoning

Alternative power generation techniques are well-known in medical device engineering, with energy harvesting representing a predictable solution to battery limitation challenges

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857218 and the disclosed technical variations, a person having ordinary skill in the art would find the proposed subcutaneous delivery system modifications obvious and lacking inventive step. The incremental technological improvements represent predictable extensions of existing subcutaneous monitoring device technologies, thereby rendering potential patent claims obvious under 35 U.S.C. Section 103 standard.

Original Patent Information

Patent Number	US 11,857,218
Title	Subcutaneous delivery tool
Assignee(s)	Medtronic, Inc.